Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Synthesis and evaluation of a hydrophilic 18F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography

Paulo Nunes, Zhengxing Zhang, Hsiou-Ting Kuo, Chengcheng Zhang, Julie Rousseau, Etienne Rousseau, Joseph Lau, Daniel Kwon, Ivone Carvalho, Francois Benard and Kuo-Shyan Lin
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1136;
Paulo Nunes
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
2School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengxing Zhang
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsiou-Ting Kuo
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengcheng Zhang
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Rousseau
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Etienne Rousseau
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Lau
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Kwon
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivone Carvalho
2School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Shyan Lin
1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 59 no. supplement 1 1136

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.

Copyright & Usage 
© 2018

Author Information

  1. Paulo Nunes1,2,
  2. Zhengxing Zhang1,
  3. Hsiou-Ting Kuo1,
  4. Chengcheng Zhang1,
  5. Julie Rousseau1,
  6. Etienne Rousseau1,
  7. Joseph Lau1,
  8. Daniel Kwon1,
  9. Ivone Carvalho2,
  10. Francois Benard1 and
  11. Kuo-Shyan Lin1
  1. 1Department of Molecular Oncology BC Cancer Research Centre Vancouver BC Canada
  2. 2School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto Brazil

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2018 to April 2025

AbstractFullPdf
May 2018200
Jun 20182300
Jul 2018500
Aug 2018600
Sep 20181000
Oct 20186900
Nov 20181500
Dec 2018800
Jan 20191100
Feb 2019900
Mar 2019700
Apr 20192300
May 2019500
Jun 2019300
Jul 2019400
Aug 2019400
Sep 2019300
Oct 2019400
Nov 2019200
Dec 2019600
Jan 2020500
Feb 2020100
Mar 2020300
Apr 2020500
May 2020300
Jun 2020300
Jul 2020500
Aug 2020200
Sep 2020100
Nov 2020300
Dec 2020300
Jan 2021500
Feb 2021800
Mar 2021600
Apr 2021700
May 2021600
Jun 2021100
Jul 2021500
Aug 2021400
Sep 2021600
Oct 2021300
Nov 2021400
Dec 2021200
Jan 2022400
Feb 2022400
Mar 2022300
Apr 2022100
May 2022200
Jun 2022400
Jul 2022400
Aug 2022200
Oct 2022300
Nov 2022200
Dec 2022400
Jan 2023200
Feb 2023400
Mar 2023300
Apr 2023200
May 2023300
Jun 2023200
Jul 2023200
Aug 2023500
Sep 2023300
Oct 2023200
Nov 202322200
Dec 2023400
Jan 2024700
Feb 2024100
Mar 2024400
Apr 2024300
May 2024400
Jun 2024300
Jul 2024100
Aug 20241000
Sep 2024400
Oct 2024400
Nov 2024700
Dec 2024600
Jan 2025400
Feb 2025800
Apr 2025700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and evaluation of a hydrophilic 18F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and evaluation of a hydrophilic 18F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography
Paulo Nunes, Zhengxing Zhang, Hsiou-Ting Kuo, Chengcheng Zhang, Julie Rousseau, Etienne Rousseau, Joseph Lau, Daniel Kwon, Ivone Carvalho, Francois Benard, Kuo-Shyan Lin
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1136;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and evaluation of a hydrophilic 18F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomography
Paulo Nunes, Zhengxing Zhang, Hsiou-Ting Kuo, Chengcheng Zhang, Julie Rousseau, Etienne Rousseau, Joseph Lau, Daniel Kwon, Ivone Carvalho, Francois Benard, Kuo-Shyan Lin
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 1136;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Oncology Posters

  • Targeted molecular imaging of c-Met in NSCLC using 68Ga-labeled binding peptide
  • A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
  • A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator.
Show more Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire